20% Raised

Short Summary

RaySense is an advanced analytics and data modelling platform for the Healthcare market, due to its design it can be utilized in multiple settings. Designed in partnership with Healthcare Professionals for Healthcare Professionals.

Overview

Target
£50,000
Minimum
£5,000
Investment Raised
£10,000
Previous Rounds £200,000
Stage Pre-Startup/R&D
Investor Role Weekly Involvement

Highlights

  • Large London NHS Trust & world renowned research University collaboration
  • Approved in principle to pilot tech at Harmonia Dementia Village.
  • By 2023 remote patient monitoring is expected to earn more than £24.7 bn.
  • Pressure Ulcers is a global problem £8.7bn causing bed blocking.
  • Mental health expected to cost £12.6 tn globally by 2030 if not addressed
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Featured
0% raised

Medics Academy

location_on London, United Kingdom

Imagine training all healthcare professionals a country needs through one system. Pilot with NHS; commercial contracts in place; 2,500+ users in Year 1

£ 1,000,000

Target

£ 1,000

Min per Investor

Global Pro
5% raised

MEDI-HR

location_on London, United Kingdom

MEDI-HR, which is Medical Employers Digitally Integrated HR system. >1.1 million NHS Primary Care Nurse appointments lost every year due to work related stress, this is 38,640 working days lost, and a cost to the NHS estimated >£5.1 million / year...

£ 300,000

Target

£ 50,000

Min per Investor

Pro
0% raised

Blood Coagulation monitor

location_on W. Midlands, United Kingdom

Bio-AMD have developed a highly sensitive blood coagulation system to measure INR levels of patients after cardiac heart attack, ensure that the patients drug treatment does not lead to clotting or bleed scenario. The system out perform competitors

£ 1,500,000

Target

£ 100

Min per Investor

load one similar proposal